Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Connolly SJ, et al. Among authors: champagne j. JAMA. 2006 Jan 11;295(2):165-71. doi: 10.1001/jama.295.2.165. JAMA. 2006. PMID: 16403928 Clinical Trial.
Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ Jr, Philippon F, Sami M, Rocco TA Jr, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG; AFFIRM Investigators. O'Hara GE, et al. Among authors: champagne j. Am J Cardiol. 2005 Sep 15;96(6):815-21. doi: 10.1016/j.amjcard.2005.05.027. Am J Cardiol. 2005. PMID: 16169368
Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.
Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Parkash R, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Essebag V; Canadian Heart Rhythm Society Device Advisory Committee. Krahn AD, et al. Among authors: champagne j. Heart Rhythm. 2008 May;5(5):639-42. doi: 10.1016/j.hrthm.2008.01.029. Epub 2008 Jan 29. Heart Rhythm. 2008. PMID: 18452862
Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee.
Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Turabian M, Kus T, Gardner M, Essebag V. Krahn AD, et al. Among authors: champagne j. Heart Rhythm. 2009 Apr;6(4):474-7. doi: 10.1016/j.hrthm.2009.01.012. Epub 2009 Jan 18. Heart Rhythm. 2009. PMID: 19324305
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee.
Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Parkash R, et al. Among authors: champagne j. Circulation. 2010 Jun 8;121(22):2384-7. doi: 10.1161/CIRCULATIONAHA.109.924357. Epub 2010 May 24. Circulation. 2010. PMID: 20497979
Nonphysiologic noise early after defibrillator implantation in Canada: incidence and implications: a report from the Canadian Heart Rhythm Society Device Committee.
Essebag V, Champagne J, Birnie DH, Verma A, Healey JS, Simpson CS, Kus T, Thibault B, Mangat I, Tung S, Sterns L, Exner DV, Davies T, Coutu B, Crystal E, Stephenson EA, Connors S, Paredes FA, Parkash R, Krahn AD. Essebag V, et al. Among authors: champagne j. Heart Rhythm. 2012 Mar;9(3):378-82. doi: 10.1016/j.hrthm.2011.10.025. Epub 2011 Oct 22. Heart Rhythm. 2012. PMID: 22024148
Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee.
Parkash R, Exner D, Champagne J, Mangat I, Thibault B, Healey JS, Tung S, Crystal E, Simpson C, Nery PB, Sterns L, Connors S, Cameron D, Verma A, Beardsall M, Wolfe K, Essebag V, Ayala-Paredes F, Sanatani S, Coutu B, Fraser J, Toal S, Philippon F, Tang AS, Yee R, Krahn A. Parkash R, et al. Among authors: champagne j. Heart Rhythm. 2013 May;10(5):692-5. doi: 10.1016/j.hrthm.2013.01.018. Epub 2013 Jan 17. Heart Rhythm. 2013. PMID: 23333722
The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.
Bennett MT, Ha AC, Exner DV, Tung SK, Parkash R, Connors S, Coutu B, Crystal E, Champagne J, Philippon F, Yee R, Stephenson EA, Nery PB, Essebag V, Sanatani S, Redfearn D, Krahn AD, Healey JS. Bennett MT, et al. Among authors: champagne j. Heart Rhythm. 2013 Oct;10(10):1478-81. doi: 10.1016/j.hrthm.2013.07.050. Epub 2013 Aug 22. Heart Rhythm. 2013. PMID: 23973950
Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia.
Vittoria Matassini M, Krahn AD, Gardner M, Champagne J, Sanatani S, Birnie DH, Gollob MH, Chauhan V, Simpson CS, Hamilton RM, Talajic M, Ahmad K, Gerull B, Chakrabarti S, Healey JS. Vittoria Matassini M, et al. Among authors: champagne j. Heart Rhythm. 2014 Feb;11(2):274-81. doi: 10.1016/j.hrthm.2013.11.008. Epub 2013 Nov 14. Heart Rhythm. 2014. PMID: 24239842
313 results